Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 36% ± 15% | |
| epithelial cell of proximal tubule | 5 studies | 27% ± 5% | |
| transit amplifying cell | 4 studies | 25% ± 8% | |
| enterocyte | 4 studies | 28% ± 7% | |
| B cell | 3 studies | 18% ± 2% | |
| fibroblast | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 888.59 | 180 / 180 | 100% | 7.89 | 430 / 430 |
| stomach | 100% | 2709.70 | 359 / 359 | 100% | 6.66 | 286 / 286 |
| liver | 100% | 6038.99 | 226 / 226 | 100% | 12.16 | 405 / 406 |
| intestine | 100% | 1355.59 | 965 / 966 | 100% | 7.44 | 525 / 527 |
| prostate | 100% | 805.02 | 245 / 245 | 99% | 4.17 | 499 / 502 |
| esophagus | 100% | 806.18 | 1445 / 1445 | 99% | 4.36 | 181 / 183 |
| brain | 98% | 561.59 | 2602 / 2642 | 100% | 5.07 | 704 / 705 |
| uterus | 100% | 579.13 | 170 / 170 | 98% | 4.69 | 450 / 459 |
| breast | 100% | 743.63 | 459 / 459 | 97% | 3.27 | 1081 / 1118 |
| pancreas | 100% | 886.70 | 328 / 328 | 95% | 2.33 | 169 / 178 |
| kidney | 100% | 1862.19 | 89 / 89 | 95% | 4.02 | 854 / 901 |
| bladder | 100% | 640.95 | 21 / 21 | 94% | 5.01 | 474 / 504 |
| lung | 97% | 537.47 | 560 / 578 | 92% | 2.63 | 1064 / 1155 |
| thymus | 100% | 614.99 | 653 / 653 | 88% | 2.83 | 530 / 605 |
| skin | 99% | 619.60 | 1793 / 1809 | 63% | 1.13 | 295 / 472 |
| adrenal gland | 99% | 548.10 | 256 / 258 | 37% | 0.60 | 84 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 4.55 | 29 / 29 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.33 | 1 / 1 |
| muscle | 100% | 925.69 | 802 / 803 | 0% | 0 | 0 / 0 |
| adipose | 100% | 790.65 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 896.39 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 500.99 | 240 / 241 | 0% | 0 | 0 / 0 |
| heart | 99% | 1128.98 | 850 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 3.53 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 68% | 1.15 | 54 / 80 |
| peripheral blood | 39% | 297.06 | 360 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008150 | Biological process | biological_process |
| GO_0005778 | Cellular component | peroxisomal membrane |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PXMP2 |
| Protein name | Peroxisomal membrane protein 2 Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein) |
| Synonyms | PMP22 |
| Description | FUNCTION: Seems to be involved in pore-forming activity and may contribute to the unspecific permeability of the peroxisomal membrane. |
| Accessions | ENST00000543589.5 ENST00000428960.3 F5GXM0 ENST00000539093.2 F5GZF7 F5H4N4 A0A087X249 Q9NR77 ENST00000317479.8 ENST00000454379.2 |